GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVOW) » Definitions » Total Stockholders Equity

Alvotech (Alvotech) Total Stockholders Equity : $-658.83 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Total Stockholders Equity?

Alvotech's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $-658.83 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Alvotech's Book Value per Share for the quarter that ended in Mar. 2024 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Alvotech's Debt-to-Equity for the quarter that ended in Mar. 2024 was -1.67.

Alvotech Total Stockholders Equity Historical Data

The historical data trend for Alvotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Total Stockholders Equity Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
- -867.24 -135.61 -564.42 -932.49

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -655.77 -478.54 -660.85 -932.49 -658.83

Alvotech  (NAS:ALVOW) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Alvotech's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-658.825-0)/0
=N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Alvotech's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(48.711 + 1051.178) / -658.825
=-1.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alvotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Alvotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alvotech (Alvotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVOW) » Definitions » Total Stockholders Equity
Comparable Companies
AMPH DVAX PBH IRWD TARO PCRX SUPN TLRY ANIP DCPH ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ALVO:USA ALVO:Iceland Z45:Germany
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Website
https://www.alvotech.com
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.